• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Health Insurance Exchanges Update

Article

One of the more popular sessions at the Academy of Managed Care Pharmacy 24th Annual Meeting on Thursday featured Paul Frostin, PhD, Director, Health Research and Education Program, Employee Benefit Research Institute, on the topic of health insurance exchanges.

One of the more popular sessions at the Academy of Managed Care Pharmacy 24th Annual Meeting on Thursday featured Paul Frostin, PhD, Director, Health Research and Education Program, Employee Benefit Research Institute. Frostin’s presentation, “Essential Benefits and Exchanges Update for Managed Care Pharmacy,” identified highlights of the of the Exchanges final ruling and talked about how these changes would impact managed care pharmacy. In particular, Frostin mentioned that the final rule would allow states to go beyond minimum standards. States would also be able to charge fees to carriers to cover cost of operating exchanges. As far as transparency, exchange carriers would need to provide enrollees with an enrollment package and include information on hot to access the provider directory and drug formulary.

Notable Dates

Assuming that the Supreme Court proclaims these exchanges constitutional, states that have failed to establish an exchange in the shortened timeline will have few legislative options remaining. If a state fails to establish an exchange, a federally facilitated exchange will be implemented. Following the initial setup, here are the timelines going forward:

  • Jan 2013 — Department of Health and Human Services (HHS) will certify exchanges as fully or conditionally operational
  • Oct 2013 — Open enrollment begins
  • Jan 2014 — Exchanges should be fully operational
  • Jan 2015 — Exchanges must be financially self-sustaining

But before a final rule can be made, there may need to be some clarification from HHS, such as comments on interim rules related to definitions of pharmacy benefit management, generic drugs, rebates, discounts, etc. Frostin also mentioned that, when definitional issues come into question, definitions will be aligned with the Medicare program to the extent possible. Essential health benefits per the Affordable Care Act include the following:

  • Ambulatory patient services
  • Emergency services
  • Hospitalization
  • Maternity/newborn care
  • Mental health and substance abuse service
  • Prescription drugs
  • Rehabilitative and habilitative services
  • Laboratory services
  • Preventive and wellness services
  • Pediatric services

For more information about this presentation, please visit www.amcp.org.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.